RT @IdiUcv: Vías celulares y moleculares de la COVID-19 y posibles puntos de intervención terapéutica. https://t.co/0t4k0vQaGO https://t.co…
RT @IdiUcv: Vías celulares y moleculares de la COVID-19 y posibles puntos de intervención terapéutica. https://t.co/0t4k0vQaGO https://t.co…
RT @IdiUcv: Vías celulares y moleculares de la COVID-19 y posibles puntos de intervención terapéutica. https://t.co/0t4k0vQaGO https://t.co…
RT @IdiUcv: Vías celulares y moleculares de la COVID-19 y posibles puntos de intervención terapéutica. https://t.co/0t4k0vQaGO https://t.co…
RT @IdiUcv: Vías celulares y moleculares de la COVID-19 y posibles puntos de intervención terapéutica. https://t.co/0t4k0vQaGO https://t.co…
RT @IdiUcv: Vías celulares y moleculares de la COVID-19 y posibles puntos de intervención terapéutica. https://t.co/0t4k0vQaGO https://t.co…
Vías celulares y moleculares de la COVID-19 y posibles puntos de intervención terapéutica. https://t.co/0t4k0vQaGO https://t.co/Qu0ecVSunI
RT @hussmanjp: So while I'm extremely hopeful for potential repurposed therapeutics, I'm also very concerned about those that target antibo…
RT @zzz_as_zzz: IgGのFCの糖鎖修飾でフコースが欠けてる場合の危険性に付いて憂慮している人が居ました。 https://t.co/RDL7oHSfTl この論文の単独著者。 https://t.co/5W8rI1rgqm
IgGのFCの糖鎖修飾でフコースが欠けてる場合の危険性に付いて憂慮している人が居ました。 https://t.co/RDL7oHSfTl この論文の単独著者。 https://t.co/5W8rI1rgqm
Some of these mechanisms are discussed in my Frontiers in Pharmacology paper. https://t.co/a9p6Lx1cjR
New Research: Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention https://t.co/PWDzZoqbvl #pharmacology
RT @hussmanjp: So while I'm extremely hopeful for potential repurposed therapeutics, I'm also very concerned about those that target antibo…
So while I'm extremely hopeful for potential repurposed therapeutics, I'm also very concerned about those that target antibody-mediated response, unless we clearly rule out Fc gamma-mediated inflammatory risk. My paper on cellular/molecular pathways here:
@PaulH1 Thx. Also "Covid-19 patients at his hospital began receiving sarilumab, then, later, tocilizumab. He told me that the number of patients needing intubation has since declined greatly." I'm not a cheerleader for a specific therapeutic. Just for out
@cacouteau Of course. Seems important, and consistent with the virus being "an initiator more than a perpetrator" that unleashes inflammatory host response. Zhang NLR/IgG combo noted in "Neutrophil induction and lung infiltration" section of my recent pap
RT @gomez_rial5: Nice review on cellular and molecular pathways implicated on #COVID19 inmuno pathology with potential therapeutic interven…
RT @gomez_rial5: Nice review on cellular and molecular pathways implicated on #COVID19 inmuno pathology with potential therapeutic interven…
Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention https://t.co/gtPwPhYVKB
ICYMI - my paper on #SARSCoV2 / #COVID19 was published last week in Frontiers in Pharmacology. Investigational, not prescriptive, but hopefully useful to other researchers. https://t.co/UyysWxbbSR For links to some of my other scientific papers, see here:
One positive for the variety of cellular and metabolic damage damage done by sarscov2 is that there is plenty of potential for pharmaceutical intervention, but might mean needing huge cocktail of drugs to treat it.
RT @bengoldacre: An overview of potential drug targets in Covid, although it might have been a shorter paper if they'd summarised the class…
An overview of potential drug targets in Covid, although it might have been a shorter paper if they'd summarised the classes of medication that might NOT affect covid... https://t.co/ioG6823Me8
RT @hussmanjp: My #COVID19 paper has been published in Frontiers in Pharmacology, the most-cited, peer-reviewed, open-access journal in the…
RT @hussmanjp: My #COVID19 paper has been published in Frontiers in Pharmacology, the most-cited, peer-reviewed, open-access journal in the…
RT @hussmanjp: My #COVID19 paper has been published in Frontiers in Pharmacology, the most-cited, peer-reviewed, open-access journal in the…
Frontiers | Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention | Pharmacology https://t.co/rlmBMKdhDb
RT @gomez_rial5: Nice review on cellular and molecular pathways implicated on #COVID19 inmuno pathology with potential therapeutic interven…
@zaelefty "It didn't work! Aim for his character!" Similar: How can a *finance* guy be getting medical papers published? Self-taught? Really? What an unethical thing. Time to cancel the medical journal and him. https://t.co/HzmlSOQv7Y
Nice review on cellular and molecular pathways implicated on #COVID19 inmuno pathology with potential therapeutic intervention points @FrontiersIn via @JukeBaRosh https://t.co/UigLzQ61Dg
RT @hussmanjp: My #COVID19 paper has been published in Frontiers in Pharmacology, the most-cited, peer-reviewed, open-access journal in the…
RT @JukeBaRosh: "Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention" https://t.co/0k7gkZzYA8
"Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention" https://t.co/0k7gkZzYA8
@JukeBaRosh ... and the value of a prepared retake. Oh, and you're in my acknowledgements. Thanks so much for the encouragement pal! https://t.co/a9p6LwJAVh
RT @hussmanjp: My #COVID19 paper has been published in Frontiers in Pharmacology, the most-cited, peer-reviewed, open-access journal in the…
RT @hussmanjp: My #COVID19 paper has been published in Frontiers in Pharmacology, the most-cited, peer-reviewed, open-access journal in the…
My #COVID19 paper has been published in Frontiers in Pharmacology, the most-cited, peer-reviewed, open-access journal in the field. Huge labor of love. The discussion is investigational, not prescriptive. Hope it will be useful to the research community.